Are Skin Lesion Analyzers Ready for Prime Time?
(MedPage Today) -- While the FDA is proposing to reclassify two class III computer-aided melanoma detection devices as class II devices, most members of its General and Plastic Surgery Devices Panel suggested that such a move would be premature...
Read more »